drugset / Trial / NCT04124705
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safe and effective dose conversion from levothyroxine (synthetic T4) therapy to Armour Thyroid therapy in participants who are on a stable dose of levothyroxine and have thyroid stimulating hormone (TSH) levels within the normal reference range.
Timeline
- Start
- 2019-10-11
- Primary completion
- 2021-06-22
- Completion
- 2021-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desiccated Thyroid Extract | Unknown | 0.25 unknown | Oral |
| Subject | Desiccated Thyroid Extract | Unknown | 2 unknown | Oral |
| Comparator | Levothyroxine | Other / unclassified | 25 ug | Oral |
| Comparator | Levothyroxine | Other / unclassified | 200 ug | Oral |